Evidence map›Paper›PMID 28188958›Full record

ArticleGenes, brain, and behavior2017

Potassium channel gene associations with joint processing speed and white matter impairments in schizophrenia.

H A Bruce, P Kochunov, S A Paciga, C L Hyde, X Chen, Z Xie, B Zhang, H S Xi, P O'Donnell, C Whelan and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Genes, brain, and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Voltage Gated Ion Channels and Sleep.The Journal of membrane biology · 2024
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments.International journal of molecular sciences · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

H A BruceDepartment of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD.ORCID 0000-0001-5630-3041
P KochunovDepartment of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD.
S A PacigaPfizer Inc., Worldwide Research and Development, Cambridge, MA.
C L HydePfizer Inc., Worldwide Research and Development, Cambridge, MA.
X ChenPfizer Inc., Worldwide Research and Development, Cambridge, MA.
Z XiePfizer Inc., Worldwide Research and Development, Cambridge, MA.
B ZhangPfizer Inc., Worldwide Research and Development, Cambridge, MA.
H S XiPfizer Inc., Worldwide Research and Development, Cambridge, MA.
P O'DonnellPfizer Inc., Worldwide Research and Development, Cambridge, MA.
C WhelanPfizer Inc., Worldwide Research and Development, Cambridge, MA.
C R SchubertBiogen, Cambridge, MA.
A BellonDepartment of Psychiatry, Penn State Hershey Medical Center, Hershey, PA, USA.
S A AmentDepartment of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD.
D K ShuklaDepartment of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD.
X DuDepartment of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD.
L M RowlandDepartment of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD.
H O'NeillDepartment of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD.
L E HongDepartment of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD.
Pfizer (United States) · USUniversity of Maryland, Baltimore · USBiogen (United States) · USPenn State Milton S. Hershey Medical Center · US

Funding

The Effects of Kynurenine Aminotransferase Inhibition in People with SchizophreniaP50MH103222 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI SCHWARCZ, ROBERT · 2014 to 2023
$25.2M
SOLAR-Eclipse Computational Tools for Imaging GeneticsR01EB015611 · NIBIB · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KOCHUNOV, PETER V. · 2012 to 2024
$5.0M
Multidisciplinary Schizophrenia Research TrainingT32MH067533 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI CARPENTER, WILLIAM T., ELMER, GREGORY I · 2004 to 2025
$4.3M
Amish Connectome Project on Mental IllnessU01MH108148 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI HONG, L ELLIOT ELLIOT, KOCHUNOV, PETER V. · 2015 to 2018
$4.3M
Shared Neural Circuitry in Comorbid Schizophrenia and Nicotine AddictionR01DA027680 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI HONG, L ELLIOT ELLIOT · 2010 to 2014
$2.4M
Neural Oscillatory Biomarkers for Genetics and Animal Models of SchizophreniaR01MH085646 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI HONG, L ELLIOT ELLIOT · 2010 to 2013
$2.2M
The Role of Stress-Immune-Connectome Disruption in Mechanisms of Chinese Early Schizophrenia SpectrumR01MH112180 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI HONG, L ELLIOT ELLIOT · 2017 to 2021
$1.0M
NIBIB NIH HHS R01 EB015611NIDA NIH HHS R01 DA027680NIMH NIH HHS P50 MH103222NIMH NIH HHS R01 MH085646NIMH NIH HHS R01 MH112180NIMH NIH HHS T32 MH067533NIMH NIH HHS U01 MH108148
6 · The paper itself

Abstract

Patients with schizophrenia show decreased processing speed on neuropsychological testing and decreased white matter integrity as measured by diffusion tensor imaging, two traits shown to be both heritable and genetically associated indicating that there may be genes that influence both traits as well as schizophrenia disease risk. The potassium channel gene family is a reasonable candidate to harbor such a gene given the prominent role potassium channels play in the central nervous system in signal transduction, particularly in myelinated axons. We genotyped members of the large potassium channel gene family focusing on putatively functional single nucleotide polymorphisms (SNPs) in a population of 363 controls, 194 patients with schizophrenia spectrum disorder (SSD) and 28 patients with affective disorders with psychotic features who completed imaging and neuropsychological testing. We then performed three association analyses using three phenotypes - processing speed, whole-brain white matter fractional anisotropy (FA) and schizophrenia spectrum diagnosis. We extracted SNPs showing an association at a nominal P value of <0.05 with all three phenotypes in the expected direction: decreased processing speed, decreased FA and increased risk of SSD. A single SNP, rs8234, in the 3' untranslated region of voltage-gated potassium channel subfamily Q member 1 (KCNQ1) was identified. Rs8234 has been shown to affect KCNQ1 expression levels, and KCNQ1 levels have been shown to affect neuronal action potentials. This exploratory analysis provides preliminary data suggesting that KCNQ1 may contribute to the shared risk for diminished processing speed, diminished white mater integrity and increased risk of schizophrenia.

Indexed as

Polymorphism, Single Nucleotide3' Untranslated RegionsAction PotentialsAdultCase-Control StudiesFemaleHumansKCNQ1 Potassium ChannelMaleMiddle AgedReaction TimeSchizophreniaWhite Matter3' Untranslated RegionsKCNQ1 Potassium ChannelKCNQ1 protein, humanDiffusion tensor imagingendophenotypefractional anisotropyGWASimaging geneticsKCNQ1potassium channelsprocessing speedpsychiatric geneticswhite matter

Identifiers

PMID28188958
PMCPMC5457349
OpenAlexW2587485477

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.